Benicar is a brand name for the angiotensin ii receptor antagonist olmesartan. Olmesartan works by blocking the interaction of angiotensin ii with its type 1 receptor in the vascular wall. This blockade prevents the vasoconstrictive signal, allowing blood vessels to relax. As a result, peripheral resistance decreases and blood pressure is lowered. The medication also reduces the secretion of aldosterone, which contributes to sodium and water excretion. The combined effect of reduced vasoconstriction and lower aldosterone activity improves cardiovascular workload. These physiological actions make Benicar useful for treating hypertension.

Benicar is an angiotensin ii receptor blocker used to treat high blood pressure. Its therapeutic role is to reduce vascular resistance and improve blood flow. The compound works by selectively binding to the at1 receptor on vascular smooth muscle. This binding prevents the action of angiotensin ii which normally causes constriction and sodium retention. By blocking this receptor Benicar promotes vasodilation and decreases systemic vascular tone. The resulting lowering of blood pressure provides clinical benefit in hypertension management.

The most common side effects include mild headache and temporary fatigue. Some people experience mild nausea or stomach discomfort. Skin redness or bruising may appear at the injection site. Dizziness and mild sweating are also reported in a small number of cases. These effects typically resolve within a short period without intervention. While generally benign they illustrate the body's response to the treatment.

The most common side effects observed across various treatments include mild fatigue. Headaches are frequently reported by patients during initial therapy phases. Nausea often appears as a transient reaction that diminishes over time. Dizziness can occur when adjustments to dosage are made. Skin irritation may develop at sites of topical application. Changes in taste perception are noted by some individuals participating in clinical studies. Mild muscle aches have been documented as a common complaint. These reactions generally subside without intervention and are considered expected.